Metformin and fluoxetine improve depressive-like behavior in a murine model of Parkinsońs disease through the modulation of neuroinflammation, neurogenesis and neuroplasticity
- 1 January 2022
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 102, 108415
Abstract
No abstract availableKeywords
Funding Information
- Fundação Oswaldo Cruz (-007-FIO-18-2-17)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
This publication has 54 references indexed in Scilit:
- Exercise effects on motor and affective behavior and catecholamine neurochemistry in the MPTP-lesioned mouseBehavioural Brain Research, 2010
- Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic interventionNeurobiology of Disease, 2010
- Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major DepressionBiological Psychiatry, 2009
- The neuropathological basis for depression in Parkinson's diseaseParkinsonism & Related Disorders, 2009
- Drug-Dependent Requirement of Hippocampal Neurogenesis in a Model of Depression and of Antidepressant ReversalBiological Psychiatry, 2008
- Dose translation from animal to human studies revisitedThe FASEB Journal, 2007
- High-Speed Imaging Reveals Neurophysiological Links to Behavior in an Animal Model of DepressionScience, 2007
- Antidepressant drugs reverse the loss of adult neural stem cells following chronic stressJournal of Neuroscience Research, 2007
- Requirement of Hippocampal Neurogenesis for the Behavioral Effects of AntidepressantsScience, 2003
- Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled studyJournal of Neurology, Neurosurgery & Psychiatry, 2002